Biological assets (Tables)

12 Months Ended

Dec. 31, 2020

Biological assets

Schedule of reconciliation of the carrying amounts of the biological assets

Balance at December 31, 2018	$	4,491
Assets obtained in the acquisition of HMS Companies		469
Assets obtained in the acquisition of Eureka		577
Assets obtained in the acquisition of Acres		567
Unrealized fair value gain on growth of biological assets		97,738
Increase in biological assets due to capitalized costs		20,661
Transferred to inventory upon harvest		(105,306)
Balance at December 31, 2019	$	19,197
Assets obtained in the acquisition of Remedy		79
Assets obtained in the acquisition of Curaleaf NJ		2,340
Assets obtained in the acquisition of MEOT		705
Assets obtained in the acquisition of Grassroots		4,571
Assets obtained in the acquisition of ATG		379
Unrealized fair value gain on growth of biological assets		224,610
Increase in biological assets due to capitalized costs		109,850
Transferred to inventories upon harvest		(314,114)
Transferred to assets held for sale		(1,407)
Balance at December 31, 2020	$	46,210